Intellia Therapeutics (NTLA) Stock Chart & Stock Price History $10.73 +0.85 (+8.60%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$10.88 +0.15 (+1.35%) As of 05:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Intellia Therapeutics Stock Price Performance The Intellia Therapeutics (NTLA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 53.25%, with a year-to-date return of -7.98%. In the past month, the stock has increased 39.53%, reflecting recent market activity. As of the latest close, Intellia Therapeutics traded at $10.73 with a market cap of $1.11 billion and volume of 7.23 million shares. Five years ago, the stock traded at $22.30, representing a 51.88% decrease over that period. At the time, it had a market cap of $1.14 billion and a volume of 650,738 shares. Receive NTLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.24%1 Month Performance+39.53%3 Month Performance+55.73%Year-To-Date Performance-7.98%1 Year Performance-53.25%5 Year Performance-51.88% NTLA Stock Chart for Thursday, July, 3, 2025 NTLA Chart by TradingView Intellia Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$9.88$10.73+8.60%$11.08$9.897.23 million shs$1.11 billion07/01/2025$9.38$9.88+5.33%$10.13$8.985.56 million shs$1.02 billion06/30/2025$9.56$9.38-1.88%$9.68$9.332.74 million shs$971.61 million06/27/2025$9.61$9.56-0.52%$10.14$9.514.00 million shs$990.23 million06/26/2025$9.56$9.61+0.52%$9.74$9.452.98 million shs$995.40 million06/25/2025$9.57$9.56-0.10%$9.66$9.303.23 million shs$990.23 million06/24/2025$9.23$9.57+3.68%$9.92$9.295.29 million shs$991.26 million06/23/2025$9.20$9.23+0.33%$9.51$8.883.94 million shs$956.04 million06/20/2025$9.60$9.20-4.17%$9.94$8.955.90 million shs$952.94 million06/19/2025$9.60$9.60$9.71$9.015.76 million shs$994.37 million Get the Latest News and Ratings for NTLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$9.58$9.60+0.21%$9.71$9.015.76 million shs$994.37 million06/17/2025$8.96$9.58+6.92%$10.52$9.5310.37 million shs$992.33 million06/16/2025$8.31$8.96+7.82%$9.11$8.255.17 million shs$928.10 million06/13/2025$8.35$8.31-0.48%$8.48$8.003.28 million shs$860.78 million06/12/2025$8.37$8.35-0.24%$8.45$8.062.50 million shs$864.92 million06/11/2025$8.47$8.37-1.18%$8.69$8.223.71 million shs$866.99 million06/10/2025$8.28$8.47+2.29%$9.13$8.365.13 million shs$877.35 million06/09/2025$8.09$8.28+2.35%$8.77$8.006.89 million shs$857.67 million06/06/2025$7.58$8.09+6.73%$8.40$7.757.21 million shs$837.99 million06/05/2025$7.67$7.58-1.17%$7.88$7.314.33 million shs$785.16 million06/04/2025$7.69$7.67-0.26%$7.84$7.523.97 million shs$794.48 million06/03/2025$7.16$7.69+7.40%$7.76$6.985.71 million shs$796.55 million06/02/2025$6.99$7.16+2.43%$7.59$6.927.96 million shs$741.65 million Related Companies ACADIA Pharmaceuticals Stock Price Chart Merus Stock Price Chart SpringWorks Therapeutics Stock Price Chart Avidity Biosciences Stock Price Chart Arcellx Stock Price Chart Ultragenyx Pharmaceutical Stock Price Chart Protagonist Therapeutics Stock Price Chart Ascentage Pharma Group International Stock Price Chart Scholar Rock Stock Price Chart Metsera Stock Price Chart Receive NTLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NTLA) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
